MENU
+Compare
REPL
Stock ticker: NASDAQ
AS OF
Jul 15, 10:30 AM (EDT)
Price
$11.51
Change
+$0.23 (+2.04%)
Capitalization
869.54M

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for REPL with price predictions
Jul 14, 2025

Momentum Indicator for REPL turns positive, indicating new upward trend

REPL saw its Momentum Indicator move above the 0 level on July 07, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for REPL just turned positive on July 09, 2025. Looking at past instances where REPL's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REPL advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 198 cases where REPL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REPL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

REPL broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.091) is normal, around the industry mean (17.480). P/E Ratio (0.000) is within average values for comparable stocks, (59.327). REPL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.459). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (273.307).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. REPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 72.54% to -84 cents per share on July 31

Replimune Group REPL Stock Earnings Reports
Q2'25
Est.
$-0.84
Q1'25
Missed
by $2.35
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.08
The last earnings report on May 22 showed earnings per share of -306 cents, missing the estimate of -72 cents. With 2.08M shares outstanding, the current market capitalization sits at 869.54M.
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PFSAX24.65N/A
N/A
PGIM Jennison Financial Services A
PRJBX45.64N/A
N/A
PGIM Jennison Global Opportunities R2
FAPHX13.01N/A
N/A
Fidelity Healthy Future
EITGX56.78N/A
N/A
Eaton Vance Tx-Mgd Growth 1.2 I
SEVIX14.67N/A
N/A
SEI US Managed Volatility I (SIMT)

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with ELVAF. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+2.83%
ELVAF - REPL
60%
Loosely correlated
N/A
SNDX - REPL
51%
Loosely correlated
+2.71%
IDYA - REPL
50%
Loosely correlated
+0.44%
XNCR - REPL
50%
Loosely correlated
+0.23%
CGON - REPL
47%
Loosely correlated
-3.07%
More